Medical device company Salutaris Medical Devices (SalutarisMD) has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its SMD-Sr90-DA Radionuclide Brachytherapy Source (RBS).

Planned to be used for a manual brachytherapy applicator system, the SMD-Sr90-DA RBS device can also be utilised for a episcleral brachytherapy procedure.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

SalutarisMD's chief executive officer (CEO) Dr Laurence Marsteller said: "The SalutarisMD team is quite proud and excited to have reached this important regulatory and commercial milestone.

“It further validates our company's progress and advances its clinical research agenda."

The company is currently developing a minimally invasive procedure, which can be performed in an outpatient setting in around 15 minutes. According to SalutarisMD, the patented and patent-pending technology provides a single-use brachytherapy procedure.

"The SalutarisMD team is quite proud and excited to have reached this important regulatory and commercial milestone."

In October this year, SalutarisMD obtained a global certification for medical device quality systems, ISO 13485:2003, enabling the company to commercialise its technology to treat wet age-related macular degeneration (wet AMD).

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The ISO 13485:2003 certification also includes the design, development, production, and distribution of medical devices produced by SalutarisMD.

A month before receiving the certification, SalutarisMD announced its plan to introduce its new generation, commercial-ready episcleral brachytherapy applicator system.

The new system, SMD-DA, is designed to provide better dosimetry to wet AMD lesions and improved ease of use for retinal surgeons.

SalutarisMD has already obtained US regulatory approval for an upcoming clinical study using the new device.

Image: SalutarisMD SMD-DA applicator. Photo: courtesy of Business Wire.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact